Doma Perpetual Capital Management LLC
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Doma Perpetual Capital Management LLC reported 12 stock positions worth $355.6 million. Its top holding was Pacira Biosciences (PCRX) at 20.2% of the portfolio, followed by Inmode (INMD, 11.7%) and Merchants Bancorp (MBIN, 10.7%). Compared with Q3 2025, it opened 1 new position, sold out of 1, added to 5 and reduced 3. The biggest buy was Merchants Bancorp (MBIN, shares +1089%) and the biggest sale Napco Security Technologies (NSSC, shares −46%).
- Most Recent 13F
- Q2 2026
- Location
- Miami, FL
- CIK
- 0001962221
- Portfolio Value
- $355.6M (Q4 2025)
- SEC Filing
- 0001172661-26-000872 ↗ filed Feb 17, 2026
Holdings Value
Holdings 12 stocks · $355.6M
| PCRX Pacira Biosciences Inc. | 20.21% | 2,777,794 | $71.9M | Add +2.8% |
| INMD Inmode Ltd. | 11.72% | 2,838,431 | $41.7M | No change |
| MBIN Merchants Bancorp | 10.68% | 1,115,594 | $38.0M | Add +1088.9% |
| NOMD Nomad Foods Ltd. | 10.04% | 2,852,848 | $35.7M | Add +1633.2% |
| DVA Davita Inc. | 9.68% | 302,883 | $34.4M | Reduce -14.8% |
| HIFS Hingham Institution for SVGS | 9.37% | 117,354 | $33.3M | Add +34.0% |
| AFYA Afya Ltd. Class A | 9.03% | 2,083,258 | $32.1M | Add +133.6% |
| NSSC Napco Security Technologies | 7.36% | 627,931 | $26.2M | Reduce -46.1% |
| KNSL Kinsale Capital Group Inc. | 6.16% | 56,051 | $21.9M | New |
| PLGO Pelagos Insurance Capital LT filed as FIDELIS INSURANCE HOLDINGS L | 3.50% | 636,912 | $12.5M | No change |
| BBD Banco Bradesco-ADR | 1.88% | 2,005,430 | $6.7M | No change |
| SIRI Sirius XM Holdings Inc. | 0.36% | 63,712 | $1.3M | Reduce -94.5% |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
| MBIN Merchants Bancorp | Add +1088.9% | 10.68% | +9.68 |
| NOMD Nomad Foods Ltd. | Add +1633.2% | 10.04% | +9.31 |
| KNSL Kinsale Capital Group Inc. | New | 6.16% | +6.16 |
| AFYA Afya Ltd. Class A | Add +133.6% | 9.03% | +4.36 |
| HIFS Hingham Institution for SVGS | Add +34.0% | 9.37% | +1.62 |
| PCRX Pacira Biosciences Inc. | Add +2.8% | 20.21% | −3.16 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 13 | $430.8M | PCRX, NOMD, MBIN, INMD, HIFS |
| Q1 2026 | 11 | $372.4M | PCRX, DVA, MBIN, INMD, AFYA |
| Q4 2025 | 12 | $355.6M | PCRX, INMD, MBIN, NOMD, DVA |
| Q3 2025 | 12 | $297.8M | PCRX, NSSC, DVA, INMD, SIRI |
| Q2 2025 | 10 | $264.0M | BBD, PCRX, DVA, NSSC, INMD |
| Q1 2025 | 10 | $254.4M | PCRX, DVA, INMD, BBD, NSSC |
| Q4 2024 | 8 | $201.0M | INMD, PCRX, SIRI, BBD, NSSC |
| Q3 2024 | 8 | $198.0M | INMD, BBD, NSSC, SIRI, PCRX |
| Q2 2024Amended | 9 | $215.6M | DVA, INMD, PCRX, BBD, LSXMK |
| Q1 2024Amended | 9 | $150.3M | DVA, LSXMK, PCRX, INMD, NSSC |